Demand for Precision and High-Throughput in Lab Workflows
Liquid handling systems have gained a major driver for their adoption with the growing need for precision, efficiency, and high-throughput laboratory workflows in public health, clinical diagnostics, and scientific research institutions. Government-backed laboratory automation projects and reports are indicating that the use of liquid handling robots in laboratory automation systems is going to become a standard in modern workflows that will minimize human errors and improve reproducibility. To illustrate, the global market for lab automation systems (including liquid handlers) was valued at about US-$6.7-billion in 2025, which was totally a result of the very high demands imposed on the drug discovery and clinical diagnostics workflow areas. This demand trend for liquid handlers continued into 2023 and 2025 due to the fact that laboratories around the world were increasingly adopting robotics and automation to perform such tasks as PCR setup, ELISA, and next-generation sequencing workflows with much higher accuracy and lower manual variability. Moreover, this trend was facilitated by the availability of official funding for research infrastructure, especially from the NIH, as well as other national R&D funding streams that prioritize automated laboratory platforms for the handling of complex biological assays that are impractical or prone to errors when done manually. Furthermore, reports from reliable sources indicate that in 2023 there were, worldwide, large installations of automated liquid handling units, with many labs transforming into, digital systems that are scalable and support reproducible analysis and remote monitoring—an evolution that was dramatically increased by the pandemic era's pressure of having to safely handle large sample volumes.
Laboratory stakeholders are increasingly investing in liquid handling to support precision public health testing and research workflows. This is driven not only by new product developments, such as: AI-integrated pipetting platforms, cloud-enabled automation controls, modular robotic workstations, and acoustic dispensing systems that were launched between 2023-2025.
Personalized Medicine and Genomics Workflows
Liquid handling systems are presented a significant chance above all within the personalized medicine, genomics, and complex biopharma applications that continue to expand. Officially, laboratories' automation market insights indicate that institutions around the globe are investing more in technologies like ultra-low volume dispensers, complex sample preparation, and high-throughput genomic analysis which mainly the growing demand for individualized treatment protocols and population-level disease surveillance is responsible for this trend. In the year 2025 the wider laboratory automation systems industry was already billion dollars worth and one of the factors for this situation was the need for high-precision liquid handling in genomic and proteomic assays. The number of automated liquid handling units that were installed across pharmaceutical research, diagnostics, and academic labs was over 82,000 in the year 2023. The modular and scalable systems that support various workflows like single-cell analysis and precision oncology sample prep attracted strong demand. This trend of adoption continued in 2025 as laboratories were demanding more and more flexible platforms that could work with micro- and nanoliter volumes for personalized drug screening, biomarker discovery, and clinical assay development. Moreover, the product developments that are on the verge of being introduced bolster this opportunity: for example, AI-assisted liquid handling workflow optimization, acoustic or piezoelectric low-volume dispensing, IoT-enabled remote control, and enhanced contamination control were the concepts presented by leading manufacturers during the period of 2023-2025. This technology helps in the fast and reliable processing of difficult sample types and is also very suitable for the high-precision and flexible requisites of the advanced genomics and cell-based workflows.
The demand created by the government-supported precision medicine initiatives (e.g., national genomic projects and public health laboratory upgrades) is further stimulating the market, thus opening a door for the vendors to come up with solutions that are specifically designed for the clinical and research environments where both performance and regulatory compliance are required.
